Paraguay vs Serbia: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Paraguay
91.0%
in 2025
Serbia
91.0%
in 2025
Paraguay rank
61st
Serbia rank
61st
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Paraguay
- Serbia
How they compare
Paraguay currently reports 91.0% against 91.0% in Serbia, a difference of 0.0%.
The two have swapped places 4 times across 18 shared years of data; in 2008 it was Serbia ahead.
Paraguay ranks 61st and Serbia ranks 61st of 194 countries.
Across the 3 decades both report, Paraguay averaged higher in 1 and Serbia in 1.
Head to head by decade
| Decade | Paraguay | Serbia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 72.3% | 15.9% | 56.4% | Paraguay |
| 2020s | 79.5% | 87.5% | 8.0% | Serbia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Paraguay or Serbia?
- Paraguay, at 91.0% against 91.0% in Serbia as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Paraguay and Serbia?
- 0.0%, with Paraguay ahead.
- How many years of comparable data are there for Paraguay and Serbia?
- 18 years are reported by both, from 2008 to 2025.
- How do Paraguay and Serbia rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Paraguay ranks 61st and Serbia ranks 61st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.